# Arch Therapeutics, Inc.

- Location (FDA's records): Framingham, MA
- FDA decisions: 2 (2018–2020): 2 510(k) clearances
- Product codes: FRO (2)
- Predicates its devices cite: 3 (1 its own); citations of its devices by later devices: 1 (1 its own)
- Recalls linked to its devices: 0 (0 Class I)
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Firms whose devices it cites most
- 3-D Matrix, Inc.: 1 (https://510kreport.com/company/3-d-matrix)
- Convatec, A Bristol-Myers Squibb Co.: 1 (https://510kreport.com/company/convatec-a-bristol-myers-squibb)

## Its most-cited devices
- K182681: AC5 Topical Gel (2018), cited by 1

## Recent decisions
- K190129: AC5 Topical Gel (Mar 11, 2020)
- K182681: AC5 Topical Gel (Dec 14, 2018)

Source page: https://510kreport.com/company/arch-therapeutics